Company Website:
http://www.teleflex.com
WAYNE, Pa. -- (Business Wire)
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
technologies for critical care, urology and surgery, will showcase its
Arrow® Interventional Access Portfolio at the 2nd Annual Congress of the
European Society for Vascular Medicine (ESVM) to be held in Rome, Italy
on May 8 – 10, 2016.
During the event, Teleflex will highlight the Arrow® GPSCath® Balloon
Dilatation Catheter featuring innovative VisioValve® Technology over a
0.014 guidewire - for infrapopliteal interventions.
The Arrow® GPSCath® Catheter is a specialty two-in-one device that is
indicated for percutaneous transluminal angioplasty (PTA) in the
peripheral vasculature, including iliac, femoral, popliteal,
infrapopliteal and renal arteries allowing the physician to conduct
angioplasty and inject fluid (targeted angiogram specifically at lesion
site) while maintaining catheter and guidewire position. Below-the-knee
interventions can be complex undertakings, requiring multiple devices,
numerous procedural steps and significant procedural time. The Arrow®
GPSCath® Catheter offers a solution by combining angioplasty and
angiography into one device.
Prof. Marianne Brodmann, University Hospital Graz, Austria, will present
the Arrow® GPSCath® Balloon Dilatation Catheter with a recorded
live-case "Popliteal and BTK trifurcation occlusion in dialyzed diabetic
Rutherford 5" on Monday May 9, at 10:09 a.m., during the Symposium:
Endovascular Techniques and Arterial Revascularisation held from
09:00-10:30 a.m. in the Dali Auditorium.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rusch®
and Weck® – trusted brands united by a common sense of
purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, GPSCath, Hudson RCI,
LMA, Pilling, Rüsch, VisioValve and Weck are trademarks or registered
trademarks of Teleflex Incorporated or its affiliates, in the U.S.
and/or other countries. © 2016 Teleflex Incorporated. All rights
reserved.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160502005129/en/
Contacts:
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
or
Martina
Teichmann-Zindler
Director Marketing Communications International
+49
(0)7151-406-538
martina.teichmann@teleflex.com
Source: Teleflex Incorporated
© 2024 Canjex Publishing Ltd. All rights reserved.